Treatment Insomnia Ramelteon Pharmaceutical Ramelteon powder Ramelteon
Product Description
Product Details
Product Name | Ramelteon |
CAS NO. | 196597-26-9 |
Purity | 99% |
Density | 1.119 |
Appearance and shape | White powder |
Ramelteamide (also translated as lamitirone) approved by the FDA in September 2005 to be marketed in the United States, with the trade name Rozerem, can be used to treat insomnia with difficulty falling asleep, and has definite effects on chronic insomnia and short-term insomnia. This product can selectively activate the type 1 and type 2 receptors of melatonin (MT1, MT2), increase slow wave sleep (SWS) and rapid eye movement sleep (REW), thereby reducing insomnia. Ramelteamide is the first non-addictive insomnia treatment drug that is not under special control. This product is a melatonin receptor agonist. It has a high affinity with the melatonin MT1 and MT2 receptors, and has a specific and complete agonistic effect on the MT1 and MT2 receptors, but does not interact with the MT3 receptor. In addition, it does not bind to neurotransmitter receptors such as GABA receptor complexes, and does not interfere with the activity of most enzymes within a certain range. Therefore, it can avoid the distraction associated with GABA drugs (which may cause car accidents, falls and fractures). Etc.) and drug addiction and dependence.Application & Function
1. Treating insomnia (trouble falling asleep). It may also be used for other conditions as determined by your doctor.
2. Ramelteon is a melatonin agonist. It works by acting on the melatonin receptors in the brain, which helps you fall asleep.
Specification